Cargando…
Anticoagulation and dialysis access practice in home haemodialysis in the UK
Anticoagulation is an important component of haemodialysis treatment in all settings. The therapeutic options available for anticoagulation of home haemodialysis are similar to those for haemodialysis in other settings. However, dialysis sessions with a wide range of treatment durations are undertak...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421460/ https://www.ncbi.nlm.nih.gov/pubmed/25949511 http://dx.doi.org/10.1093/ndtplus/sfr132 |
_version_ | 1782369874316623872 |
---|---|
author | Breen, Cormac |
author_facet | Breen, Cormac |
author_sort | Breen, Cormac |
collection | PubMed |
description | Anticoagulation is an important component of haemodialysis treatment in all settings. The therapeutic options available for anticoagulation of home haemodialysis are similar to those for haemodialysis in other settings. However, dialysis sessions with a wide range of treatment durations are undertaken at home, which can require different approaches to anticoagulation. Conference delegates were asked about the types of anticoagulation used in home dialysis and about surveillance strategies for monitoring vascular access, and the results are presented and discussed. |
format | Online Article Text |
id | pubmed-4421460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44214602015-05-06 Anticoagulation and dialysis access practice in home haemodialysis in the UK Breen, Cormac NDT Plus Articles Anticoagulation is an important component of haemodialysis treatment in all settings. The therapeutic options available for anticoagulation of home haemodialysis are similar to those for haemodialysis in other settings. However, dialysis sessions with a wide range of treatment durations are undertaken at home, which can require different approaches to anticoagulation. Conference delegates were asked about the types of anticoagulation used in home dialysis and about surveillance strategies for monitoring vascular access, and the results are presented and discussed. Oxford University Press 2011-12 /pmc/articles/PMC4421460/ /pubmed/25949511 http://dx.doi.org/10.1093/ndtplus/sfr132 Text en © The Author 2011. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Articles Breen, Cormac Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title | Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title_full | Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title_fullStr | Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title_full_unstemmed | Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title_short | Anticoagulation and dialysis access practice in home haemodialysis in the UK |
title_sort | anticoagulation and dialysis access practice in home haemodialysis in the uk |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421460/ https://www.ncbi.nlm.nih.gov/pubmed/25949511 http://dx.doi.org/10.1093/ndtplus/sfr132 |
work_keys_str_mv | AT breencormac anticoagulationanddialysisaccesspracticeinhomehaemodialysisintheuk |